Global Epigenetics Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2017
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Epigenetics Market By Product (Reagents, Kits & Assays, Instruments, Enzymes, Services, Bioinformatics Tools), Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, Chromatin Structures), Application (Oncology, Non-Oncology, Developmental Biology, Drug Discovery, Others), End-Users (Academic & Research Institutes, Pharmaceutical Companies, Biotechnology Companies, CROs), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Epigenetics Market

Global epigenetics market is expected to register a healthy CAGR of 14.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the significant advancements in technologies of epigenetics as well as rising investments and expenditure incurred to further develop the field of epigenetics.

Market Definition: Global Epigenetics Market

Epigenetics is an innovative field of study which deals with identifying and monitoring the phenotype changes in genes that are a result of changes in the chromosomes, wherein the DNA sequence is not affected. This field of study detects changes in all stages and where the patient is exposed to various toxins, chronic stresses. This field is generally implicated in the study of cancer, although the application areas is expanding drastically.

Market Drivers

  • Rising prevalence of target diseases of epigenetics technology is expected to augment growth of the market
  • Increasing levels of geriatric population globally is also expected to drive the growth of the market
  • Increasing initiatives presented by the governments and biotechnology companies to advance the technologies associated with epigenetics is also expected to foster growth in the market
  • Greater application areas of epigenetics for more than just oncology disorders is also expected to drive the market value

Market Restraints

  • High costs associated with the instruments and kits of epigenetics is expected to restrict the adoption rate
  • Lack in prevalence of skilled professionals and physicians for effective applications of epigenetics
  • Availability of strict and complicated regulations, for effective commercialization of the products is also expected to restrain the growth of the market
  • Lack of efficiency for detection of biomarkers and their validation through this technology is expected to restrain the growth of the market

Segmentation: Global Epigenetics Market

By Product

  • Reagents

    • Antibody
    • Buffer
    • Histone
    • Magnetic Bead
    • Primer
    • Others

  • Kits & Assays

    • Bisulfite Conversion Kit
    • ChIP Sequencing Kit
    • Deep Sequencing Kit
    • Whole Genome Amplification Kit
    • RNA Sequencing Kit
    • Immunoprecipitation Kit
    • 5-HMC & 5-MC Analysis Kit
    • Methyltransferase Assays
    • Histone Assays
    • Others

  • Instruments

    • Mass Spectrometers
    • Next-Generation Sequencers (NGS)
    • Quantitative Polymerase Chain Reaction (qPCRs)
    • Sonicators
    • Others

  • Enzymes

    • DNA Modifying Enzyme

      • DNA Ligases
      • DNA Polymerases
      • Others

  • Protein Modifying Enzyme

    • Acetylases
    • Methyltransferases
    • Others

  • RNA Modifying Enzyme

    • Reverse Transcriptase
    • RNA Ligases
    • Others

  • Services
  • Bioinformatics Tools

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

By Application

  • Oncology

    • Solid Tumors
    • Liquid Tumors

  • Non-Oncology

    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases

  • Developmental Biology
  • Drug Discovery
  • Others

By End-Users

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In May 2019, Souvien Therapeutics was established by Juvenescence, which will focus on development of innovative medicines for applications in neurodegenerative disorders with the help of targeting epigenetics in neurodegeneration. The company will focus on development of therapeutics to address the epigenetics mechanisms in neurodegenerations
  • In May 2018, Cellcentric announced that they had raised USD 26 million for the development of epigenetic based drug candidate for cancers till the stage of Phase 2B trials. The drug termed as, “CCS1477” has been evident to treat patients suffering from late-stage prostate cancer, being resistance against anti-androgen drugs. Cellcentric is aiming to increase its application of the drug candidate to more than just prostate cancer where the cancer is showing mutation signs of p300 and CBP proteins

Competitive Analysis:

Global epigenetics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of epigenetics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global epigenetics market are Illumina, Inc.; Merck KGaA; QIAGEN; F. Hoffmann-La Roche Ltd; Eisai Co., Ltd.; Novartis AG; Abcam plc; Diagenode s.a.; Active Motif; Zymo Research; Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies, Inc.; PerkinElmer Inc.; Bio-Rad Laboratories, Inc.; AsisChem Inc.; Enzo Life Sciences, Inc.; EpiGentek Group Inc.; BioVision Inc.; Bio-Techne; Promega Corporation; GeneTex, Inc. and Pacific Biosciences of California, Inc. among others.

Research Methodology: Global Epigenetics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global epigenetics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19